These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29656697)

  • 1. We should focus more on finding therapeutic targets for the non-inflammatory damage in MS - Commentary.
    Al Sultan AS; Stys PK
    Mult Scler; 2018 Sep; 24(10):1276-1277. PubMed ID: 29656697
    [No Abstract]   [Full Text] [Related]  

  • 2. We should focus more on finding therapeutic targets for the non-inflammatory damage in MS - No.
    't Hart BA; Weissert R
    Mult Scler; 2018 Sep; 24(10):1274-1276. PubMed ID: 29656691
    [No Abstract]   [Full Text] [Related]  

  • 3. We should focus more on finding therapeutic targets for the non-inflammatory damage in MS - Yes.
    Garber JY; Barnett MH
    Mult Scler; 2018 Sep; 24(10):1272-1274. PubMed ID: 29656673
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurodegeneration in multiple sclerosis and neuromyelitis optica.
    Kawachi I; Lassmann H
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):137-145. PubMed ID: 27671902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation, demyelination, and degeneration - recent insights from MS pathology.
    Stadelmann C; Wegner C; Brück W
    Biochim Biophys Acta; 2011 Feb; 1812(2):275-82. PubMed ID: 20637864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and degeneration in multiple sclerosis.
    Brück W; Stadelmann C
    Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis.
    Inglese M; Benedetti B; Filippi M
    J Neurol Sci; 2005 Jun; 233(1-2):15-9. PubMed ID: 15949493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bassoon proteinopathy drives neurodegeneration in multiple sclerosis.
    Schattling B; Engler JB; Volkmann C; Rothammer N; Woo MS; Petersen M; Winkler I; Kaufmann M; Rosenkranz SC; Fejtova A; Thomas U; Bose A; Bauer S; Träger S; Miller KK; Brück W; Duncan KE; Salinas G; Soba P; Gundelfinger ED; Merkler D; Friese MA
    Nat Neurosci; 2019 Jun; 22(6):887-896. PubMed ID: 31011226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegeneration in autoimmune CNS inflammation.
    Herz J; Zipp F; Siffrin V
    Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of neurodegeneration in multiple sclerosis.
    Lassmann H; van Horssen J
    FEBS Lett; 2011 Dec; 585(23):3715-23. PubMed ID: 21854776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-induced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis.
    Sun D; Newman TA; Perry VH; Weller RO
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):374-84. PubMed ID: 15305983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
    Recks MS; Bader J; Kaiser CC; Schroeter M; Fink GR; Addicks K; Kuerten S
    Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
    Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
    J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology and disease mechanisms in different stages of multiple sclerosis.
    Lassmann H
    J Neurol Sci; 2013 Oct; 333(1-2):1-4. PubMed ID: 23735777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Magnetic resonance imaging in multiple sclerosis].
    Brochet B; Dousset V
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):1025-32. PubMed ID: 12407314
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroinflammation responses and neurodegeneration in multiple sclerosis.
    Nataf S
    Rev Neurol (Paris); 2009 Dec; 165(12):1023-8. PubMed ID: 19906389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
    Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autopsy-confirmed multiple sclerosis in a white South African. A case report.
    Kies BM; Rutherfoord GS
    S Afr Med J; 1985 Sep; 68(7):485-8. PubMed ID: 4049163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.
    Bjartmar C; Wujek JR; Trapp BD
    J Neurol Sci; 2003 Feb; 206(2):165-71. PubMed ID: 12559505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.